The Top FDA 483s in 2022Add to calendar
Thursday, January 26, 2023
This webinar will summarize the most current publicly-available data on FDA-483 observations issued to pharmaceutical and medical device manufacturers. We will provide a comparative analysis of FDA-483 observations against historical data, and give you the information you need to identify high-priority compliance actions that are necessary to avert 483 observations at your next FDA inspection.
Our very own FDA regulatory expert, Regina Fullin, will discuss why/when/where the FDA issued warning letters in 2022. She will also help you avoid such consequences for your own business. This is our most popular, annual webinar!